Related references
Note: Only part of the references are listed.Effectiveness of Ezetimibe alone or in combination with twice a week atorvastatin (10 mg) for statin intolerant high-risk patients
Vasilios G. Athyros et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Patients' perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans
Antoinette Schoenthaler et al.
ANNALS OF PHARMACOTHERAPY (2008)
A Randomized trial of direct-to-patient communication to enhance adherence to β-blocker therapy following myocardial infarction
David H. Smith et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Association of early follow-up after acute myocardial infarction with higher rates of medication use
Stacie L. Daugherty et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
Cynthia A. Jackevicius et al.
CIRCULATION (2008)
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia
M. Florentin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Impact of fixed-dose combination drugs on adherence to prescription medications
Feng Pan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status
E. A. G. Joosten et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2008)
Ezetimibe-associated adverse effects: what the clinician needs to know
M. Florentin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
A comparison of community pharmacists' views of over-the-counter omeprazole and simvastatin
Derek Stewart et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Effect of coenzyme Q10 supplementation on Siwastatin-induced myalgia
Joanna A. Young et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007 (FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFIT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I-III, ARISE, getABI, RIO)
Michael Kindermann et al.
CLINICAL RESEARCH IN CARDIOLOGY (2007)
Statin-associated adverse effects beyond muscle and liver toxicity
D. N. Kiortsis et al.
ATHEROSCLEROSIS (2007)
Impact of prescription size on statin adherence and cholesterol levels
Holly A. Batal et al.
BMC HEALTH SERVICES RESEARCH (2007)
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
Vasilios G. Athyros et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Discontinuation of statin therapy and clinical outcome after ischemic stroke
Furio Colivicchi et al.
STROKE (2007)
Statin treatment withdrawal in ischemic stroke -: A controlled randomized study
M. Blanco et al.
NEUROLOGY (2007)
Fixed-dose combinations improve medication compliance: A meta-analysis
Sripal Bangalore et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Impact of adherence to statins on coronary artery disease in primary prevention
Marie-Helene Bouchard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Protective effects of coenzyme Q10 on decreased oxidative stress resistance induced by simvastatin
Aikkarach Kettawan et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Jeppe N. Rasmussen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Comparison of measures of medication persistency using a prescription drug database
Marie Hudson et al.
AMERICAN HEART JOURNAL (2007)
Lipid management and peripheral arterial disease
S. S. Daskalopoulou et al.
CURRENT DRUG TARGETS (2007)
Primary prevention of cardiovascular diseases with statin therapy - A meta-analysis of randomized controlled trials
Paaladinesh Thavendiranathan et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Impact of medication therapy discontinuation on mortality after myocardial infarction
P. Michael Ho et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Benefits, challenges, and registerability of the polypill
Peter Sleight et al.
EUROPEAN HEART JOURNAL (2006)
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina
Caroline Daly et al.
EUROPEAN HEART JOURNAL (2006)
Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: An observational study
E Van Ganse et al.
ATHEROSCLEROSIS (2006)
Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy
JJ Li et al.
MEDICAL HYPOTHESES (2006)
Patient perspectives on multiple medications versus combined pills: a qualitative study
B Williams et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations - How much is too much?
DW Roblin et al.
MEDICAL CARE (2005)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Impact of medication adherence on hospitalization risk and healthcare cost
MC Sokol et al.
MEDICAL CARE (2005)
Predictors of adherence with antihypertensive and lipid-lowering therapy
RH Chapman et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
S Perreault et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A review of the lipid-related effects of fluvastatin
EN Liberopoulos et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment
CS Stilley et al.
ANNALS OF BEHAVIORAL MEDICINE (2004)
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction - National Registry of Myocardial Infarction
FA Spencer et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS
E Lesaffre et al.
CLINICAL THERAPEUTICS (2003)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices
J Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effect of number of medications on cardiovascular therapy adherence
SJ Shalansky et al.
ANNALS OF PHARMACOTHERAPY (2002)
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study
L Wei et al.
HEART (2002)
Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice
C Vecchione et al.
CIRCULATION RESEARCH (2002)
Long-term persistence in use of statin therapy in elderly patients
JS Benner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
CA Jackevicius et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Withdrawal of statins increases event rates in patients with acute coronary syndromes
C Heeschen et al.
CIRCULATION (2002)
Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease
DE Hilleman et al.
PHARMACOTHERAPY (2001)
Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease
AD Federman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
A systematic review of the associations between dose regimens and medication compliance
AJ Claxton et al.
CLINICAL THERAPEUTICS (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Established and emerging cardiovascular risk factors
D Wood
AMERICAN HEART JOURNAL (2001)
Adverse events associated with prescription drug cost-sharing among poor and elderly persons
R Tamblyn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The Lipid Treatment Assessment Project (L-TAP) -: A multicenter survey to evaluate the percentages of dyslipidemic, patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
TA Pearson et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
